Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Common Equity: 2011-2012

Historic Common Equity for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to -$868,000.

  • Sonoma Pharmaceuticals' Common Equity rose 1819.02% to $3.1 million in Q4 2012 from the same period last year, while for Dec 2012 it was $3.1 million, marking a year-over-year increase of 1819.02%. This contributed to the annual value of -$868,000 for FY2012, which is 151.03% down from last year.
  • Sonoma Pharmaceuticals' Common Equity amounted to -$868,000 in FY2012, which was down 151.03% from $1.7 million recorded in FY2011.
  • Sonoma Pharmaceuticals' 5-year Common Equity high stood at $1.7 million for FY2011, and its period low was -$868,000 during FY2012.
  • Moreover, its 2-year median value for Common Equity was $416,500 (2011), whereas its average is $416,500.
  • Data for Sonoma Pharmaceuticals' Common Equity shows a maximum YoY tumbled of 151.03% (in 2012) over the last 5 years.
  • Yearly analysis of 2 years shows Sonoma Pharmaceuticals' Common Equity stood at $1.7 million in 2011, then tumbled by 151.03% to -$868,000 in 2012.